Melanotan 2 has no approved medical use and lacks established safety data
In a 48-week observational study, glycemic control (HbA1c), delayed gastric emptying, hospitalization rates and stimulator placements were higher in patients with type 1 diabetes with DGp than in those with type 2 diabetics with DGp
High C ratings offer tremendous power but at the cost of lifespan, while lower ratings extend cycle life but limit current output
Recently, multiple newer agents targeting tau aggregation have undergone trials with the potential to improve clinical outcomes
Here, we use a pooled, dual CRISPR screening strategy that knocks out pairs of transporters in four metabolic states glucose, galactose, OXPHOS inhibition, and absence of pyruvate designed to unmask the inter-dependence of these genes
Figure 1 The safety profile of GLP-1 receptor agonists has been evaluated in several meta-analyses